Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.32
-0.16 (-10.81%)
At close: Aug 29, 2025, 3:59 PM
1.32
-0.02%
After-hours: Aug 29, 2025, 07:59 PM EDT
Telomir Pharmaceuticals Common Stock Revenue
Telomir Pharmaceuticals Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Telomir Pharmaceuticals Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
1
Market Cap
42.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |